MiNK Therapeutics, Inc. (NASDAQ:INKT – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 178,000 shares, a growth of 237.8% from the December 15th total of 52,700 shares. Based on an average trading volume of 38,700 shares, […]
Related Keywords
, Geode Capital Management , Mink Therapeutics Inc , Renaissance Technologies , Mink Therapeutics Company Profile , Oracle Investment Management Inc , Nasdaq , Virtu Financial , Get Free Report , Investment Management , Track Capital , Capital Management , Mink Therapeutics , Nasdaq Inkt , Stinkt , Medical , Stocks , Options , Put , Call ,
comparemela.com © 2020. All Rights Reserved.